Skip to main content

Meningococcal Group B Vaccine Dosage

Medically reviewed by Drugs.com. Last updated on Aug 21, 2023.

Applies to the following strengths: fully recombinant; recombinant, OMV, adjuvanted

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Meningitis - Meningococcal

For use in adults up to 25 years old

Bexsero(R):
Two doses (0.5 mL each), IM, at least 1 month apart

Trumenba(R):
Three doses (0.5 mL each), IM, at 0, 2, and 6 months

Comments:


Use: To prevent invasive disease caused by Neisseria meningitidis serogroup B.

Usual Pediatric Dose for Meningitis - Meningococcal

For use in children 10 years and older

Bexsero(R):
Two doses (0.5 mL each), IM, at least 1 month apart

Trumenba(R):
Three doses (0.5 mL each), IM, at 0, 2, and 6 months

Comments:


Use: To prevent invasive disease caused by Neisseria meningitidis serogroup B.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

Safety and efficacy have not been established in patients younger than 10 years.

To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Reconstitution/preparation techniques:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.